Orchid Pharmed’s Injectable Cardiometabolic Therapies Unit
Dual GIP/GLP1 Revolution
New Frontiers in metabolic care
Orchid Pharmed’s Injectable Cardiometabolic Therapies Unit
At Orchid Pharmed, we are proud to present our newly established Injectable Cardiometabolic Therapies Unit, a focused team dedicated to advancing care in metabolic and cardiovascular medicine. Our mission is to empower clinicians with sophisticated, evidence-driven therapies that address the intertwined challenges of diabetes, obesity, and cardiometabolic risk.
Our Core Value Proposition
These injectables form a comprehensive approach to cardiometabolic care, from novel first-line weight and glycemic modulation, to escalation with insulin when required.
Spartina® (tirzepatide)
At the heart of our portfolio is Spartina®, a novel dual GLP-1/GIP receptor agonist that brings meaningful advances in both glycemic control and weight management. Its unique mechanism enables an integrative approach to metabolic dysfunction, offering physicians a powerful tool to tackle the complexity of cardiometabolic disease.
Melitide® and Maciza® (liraglutide-based products)
Melitide® is tailored for patients with type 2 diabetes to improve glycemic control. Additionally, it offers significant cardiovascular risk reduction, reflecting our commitment to comprehensive management of both blood glucose and cardiovascular health.
Maciza® is optimized for weight management, helping those with obesity or overweight to achieve sustained metabolic improvements.
Gylava® (insulin glargine)
Our trusted basal insulin formulation supports patients who require insulin therapy, providing stable and predictable glycemic coverage.
What Sets Us Apart
Comprehensive Cardiometabolic Care
Our portfolio targets key pathways, including appetite regulation, insulin resistance, and basal insulin requirements, enabling clinicians to provide a complete, personalized treatment.
Patient-Centered Support & Education
Beyond our therapeutic options, Orchid Pharmed is dedicated to promoting the proper and safe use of medicines. Through training, educational materials, and patient support, we assist physicians and patients in adopting effective care strategies.
Evidence-Based & Future-Focused
We continuously track clinical research and evolving guidelines to ensure our products remain up-to-date, safe, and effective in the rapidly advancing field of cardiometabolic medicine.